Article | March 12, 2025

Webinar Recap: Practical Tips for Improving Your Compliance

Read More
Article | March 11, 2025

Healthcare and FDA Compliance in 2025, Part I: FDA War Stories from the Front Lines

Read More
Article | March 06, 2025

Exercise Caution: Celebrity Endorsements of Medical Products

Read More
Article | March 04, 2025

FDA Guidance for Labeling Plant-Based Products

Read More
Article | February 27, 2025

AI Regulation and Legal Trends in the U.S and Abroad

Read More
Article | February 25, 2025

Recap: Medical Device Recalls Unpacked

Read More
Article | February 20, 2025

Product Liability Prevention: A Proactive Approach for FDA-Regulated Industries

Read More
Article | February 19, 2025

FDA Layoffs, RFK Jr. at HHS, and More Including What This Means for FDA-Regulated Companies

Read More
Article | February 13, 2025

Speaker Programs Still Under Scrutiny

Read More
Article | February 11, 2025

SIUU Final Guidance: Opportunities for Proactive Scientific Messaging

Read More
Article | February 06, 2025

State Licensing Requirements: Are You Prepared?

Read More
Article | February 04, 2025

Changes Proposed to HIPAA Security Rules

Read More
Article | January 31, 2025

Will the Trump Administration Gut the FDA?

Read More
Article | January 28, 2025

Effective Clinical Trial Agreements: What You Need to Know

Read More
Article | January 23, 2025

Recap: Key Insights for Reimbursement Support Success

Read More
Article | January 21, 2025

Sunshine Act Compliance: How to Take Action to Meet Reporting Requirements and Avoid Costly Penalties

Read More
Article | January 16, 2025

FDA Bans Red Dye No. 3: What Food and Drug Manufacturers Need to Know

Read More
Article | January 14, 2025

Streamlining Device Changes with Predetermined Change Control Plans (PCCPs)

Read More
Article | January 07, 2025

Breaking the Ice: FDA-Focused Firm Leader Sees Benefits in AI

Read More
Article | December 20, 2024

Due Diligence Decoded: Insights from In-House Counsel at Boston Program

Read More
Article | December 19, 2024

Exploring the Loper Decision: Impacts on FDA-Regulated Transactions

Read More
Article | December 18, 2024

Revealing Risk: Cybersecurity Due Diligence

Read More
Article | December 17, 2024

Honesty is the Best Policy: Navigating the DOJ’s M&A Safe Harbor

Read More
Article | December 15, 2024

Navigating the Complex Regulatory Landscape for AI/ML-Enabled Medical Devices

Read More